UPDATE 2-Juno cancer study halted after patient deaths, shares slide 30 pct

July 7 (Reuters) - A trial of Juno Therapeutics Inc's
genetically engineered cancer therapy, known as
JCAR015, was put on hold by U.S. regulators after three leukemia
patients died from side...